111 Riverbend Road
United States of America, Georgia
AviGenics is a development-stage company pursuing commercial opportunities in avian transgenesis and nuclear transfer. AviGenics is producing valuable human biopharmaceuticals and proteins in the egg whites of poultry. AviGenics’ transgenic poultry will alleviate capacity, time and cost constraints of drug discovery and production, currently felt by the pharmaceutical industry. Using the same core technologies, AviGenics is improving the agronomic traits of poultry.